Dr. Mulherin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8301 Harcourt Rd
Ste 200
Indianapolis, IN 46260Phone+1 317-415-6600Fax+1 317-415-6649
Summary
- Dr. Brian Mulherin is an oncologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Riverview Health, Witham Health Services, Richard L. Roudebush Veterans Affairs Medical Center, and Logansport Memorial Hospital. He received his medical degree from Loyola University Chicago Stritch School of Medicine and has been in practice 11 years. He is experienced in squamous cell carcinoma of the esophagus, chondrosarcoma, hodgkin's lymphoma, anemia of chronic kidney disease, and anemia of blood loss.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2006 - 2009
Loyola University Chicago Stritch School of MedicineClass of 2006
Certifications & Licensure
IN State Medical License 2009 - 2025
WI State Medical License 2008 - 2009- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsPegcetacoplan in paroxysmal nocturnal haemoglobinuria: Its use, its clinical effectiveness, and its influence on health-related quality of life and productivity.Koo Wilson, Carly Rich, Zalmai Hakimi, Regina Horneff, Jesse Fishman
European Journal of Haematology. 2024-04-01 - 1 citationsSafety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study.Christopher J Patriquin, Andrija Bogdanovic, Morag Griffin, Richard J Kelly, Jaroslaw P Maciejewski
Advances in Therapy. 2024-05-01 - 10 citationsLong-term Survival With Paclitaxel and Gemcitabine for Germ Cell Tumors After Progression Following High-Dose Chemotherapy With Tandem TransplantBrian P. Mulherin, Mary J. Brames, Lawrence H. Einhorn
American Journal of Clinical Oncology. 2015-08-01
Press Mentions
American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and NevadaApril 29th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
